Actively Recruiting
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
Led by University of Illinois at Chicago · Updated on 2026-02-23
40
Participants Needed
1
Research Sites
111 weeks
Total Duration
On this page
Sponsors
U
University of Illinois at Chicago
Lead Sponsor
N
National Institute of Nursing Research (NINR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
CONDITIONS
Official Title
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identifies as Black or African American
- Age 35 to 80 years old
- Diagnosed with chronic kidney disease (CKD) stage 1 to 4
- Self-reported sedentary time of 6 or more hours per day
- Ability to speak, read, and understand English
- Has access to a telephone
You will not qualify if you...
- Unable to walk one block
- Unable to stand from a seated position without assistance
- Uses a wheelchair, walker, or cane for all ambulation
- Has a physical or psychological condition that prevents participation, including lower-extremity amputation without prosthetic, orthopedic conditions preventing sit-to-stand movements, neurologic or psychiatric conditions preventing sit-to-stand movements, severe cognitive impairment, unstable coronary artery disease, or orthostatic hypotension
- Has had a kidney transplant
- Participated in the Patient Advisory Board
- Any other condition the investigator considers prevents participation in the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UI Health/University of Illinois Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
M
Mary Hannan, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here